OTC: IDRSF - Idorsia Ltd

Yield per half year: -59.46%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Idorsia Ltd

Extended chart Simple chart
Financial Markets by TradingView

About Idorsia Ltd

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.

more details
Its products include PIVLAZ (clazosentan), available in 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing; and QUVIVIQ (daridorexant), available in 25 and 50 mg, for the treatment of adult patients with insomnia. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase II clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета chf
Сайт https://www.idorsia.com
Цена ао 1.15
Change price per day: 0% (1.05)
Change price per week: -19.85% (1.31)
Change price per month: +40% (0.75)
Change price per 3 month: +50% (0.7)
Change price per half year: -59.46% (2.59)
Change price per year: -60.23% (2.64)
Change price per 3 year: -94.21% (18.15)
Change price per 5 year: -96.18% (27.5)
Change price per year to date: +38.16% (0.76)
All parameters

Underestimation

Title Value Grade
P/S 2.3 6
P/BV -0.3623 0
P/E 0 0
EV/EBITDA -2.69 0
Total: 4.38

Efficiency

Title Value Grade
ROA, % -59.58 0
ROE, % 30.75 9
Total: 3.17

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -2.17 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 539.77 10
Yield Ebitda, % -44.99 0
Yield EPS, % -55.07 0
Total: 3
More

Institutions Volume Share, %
Fidelity Select Portfolios - Biotechnology 4866770 2.58
Smallcap World Fund 2270994 1.2
Vanguard International Stock Index-Total Intl Stock Indx 1627551 0.86
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 958060 0.51
iShares Core MSCI EAFE ETF 628695 0.33
Fidelity Growth Company Fund 623409 0.33
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 479318 0.25
iShares MSCI EAFE Small Cap ETF 426739 0.23
Vanguard International Stock Index-Vanguard European Stock Index 252174 0.13
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 238962 0.13



Head Job title Payment Year of birth
Mr. Jean-Paul Clozel M.D. CEO & Chairman of the Board 956.86k 1955 (70 years)
Dr. Martine Clozel Executive VP & Chief Scientific Officer N/A 1955 (70 years)
Mr. Andrew C. Weiss Senior VP and Head of Investor Relations & Corporate Communications N/A 1968 (57 years)
Mr. Julien Gander L.L.M. Senior VP, Group General Counsel & Company Secretary N/A 1979 (46 years)
Mr. Alexander Khatuntsev Senior VP & Head of Global Human Resources N/A 1978 (47 years)
Dr. Guy Braunstein M.D. Executive VP & Chief Medical Officer N/A 1956 (69 years)
Mr. Olivier Lambert Senior VP & Head of Technical Operations N/A 1966 (59 years)
Mr. Markus A. Riederer Senior VP & Head of Drug Discovery Biology N/A 1962 (63 years)
Mr. Alberto Gimona M.D. Executive VP & Head of Global Clinical Development N/A 1960 (65 years)
Mr. Andre C. Muller Executive VP & CFO 1963 (62 years)

Address: Switzerland, Allschwil, Hegenheimermattweg 91 - open in Google maps, open in Yandex maps
Website: https://www.idorsia.com